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Research
The increase in breast cancer rates in recent 
decades has prompted researchers to explore 
the role of environmental factors in breast 
cancer etiology. One such factor is exposure 
to polychlorinated biphenyls (PCBs), which 
were manufactured in the United States for 
a variety of commercial uses from the 1930s 
until the late 1970s, when they were banned. 
These environmentally persistent compounds 
have exhibited endocrine system activity in the 
laboratory (Bonefeld‑Jorgensen et al. 2001; 
Letcher et al. 2002; Oenga et al. 2004) and 
thus are of concern with respect to reproduc‑
tive system effects, including breast cancer.
A systematic review found that total PCB 
exposure is not an important predictor for 
breast cancer in the general population (Negri 
et al. 2003). Some recent studies raise the 
possibility of differential genetic susceptibil‑
ity, specifically with respect to CYP1A1 poly‑
morphisms (Li et al. 2004, 2005). If adverse 
human health effects from exposure to PCBs 
exist, they would most readily be identified 
in groups with the greatest exposures, such as 
worker populations.
Electrical capacitor production work‑
ers have been followed in several studies. 
Highly exposed workers (~ 2,500 individu‑
als, including 1,318 females) in two plants 
that produced electrical capacitors in New 
York State and Massachusetts were studied 
by Brown and Jones (1981); the cohort was 
later updated by Brown (1987). The New 
York facility was included in mortality stud‑
ies by Kimbrough et al. (1999, 2003). More 
recently, Prince et al. (2006b) expanded the 
cohort to include all workers at both facili‑
ties, regardless of exposure potential, in an 
update that employed a newly developed 
job‑  exposure matrix (JEM). Workers from 
a capacitor manufacturing plant located in 
Indiana were assessed in another retrospective 
cohort study (Sinks et al. 1992). An update 
of this study (Ruder et al. 2006) used a new 
JEM to estimate exposures. PCBs were used 
in capacitor production starting in 1939 at 
the Massachusetts plant, 1946 at the New 
York plant, and 1957 at the Indiana plant. 
The United States banned production of 
PCBs in 1977 (Smith and Brown 1987).
No previous study of these capacitor worker 
cohorts found large or significant elevations for 
female breast cancer mortality, and studies that 
examined exposure–response trends by duration 
(Prince et al. 2006a) or exposure level (Prince 
et al. 2006b) found no significant results. 
However, mortality is not a sensitive end point 
for outcomes with a high survival rate, such as 
breast cancer. Therefore, we decided to assess 
the relation between PCB exposure and female 
breast cancer incidence in a combined study of 
these three capacitor worker cohorts.
Materials and Methods
The study population consisted of women 
included in prior retrospective cohort mor‑
tality studies of workers at three capacitor 
manufacturing plants in the United States. 
Plants 1 and 2, located in New York State 
and Massachusetts, respectively, employed a 
total of 13,321 women. Plant 3, located in 
Indiana, had 857 female employees. From the 
combined base cohort of 14,178 potentially 
PCB‑exposed women, we restricted the pres‑
ent study to the 5,752 women who worked 
for at least 1 year at any of the three capaci‑
tor plants (41% of the total). The minimum 
employment restriction was motivated by 
the difficulty in locating women with short‑
term employment for questionnaire follow‑
up. Follow‑up for breast cancer incidence 
began after 1 year of employment. This 
project received approval from the National 
Institute for Occupational Safety and Health 
(NIOSH) Human Subjects Review Board 
(HSRB). Per the HSRB‑approved proto‑
col, a returned questionnaire was considered 
implied informed consent. For study partici‑
pants interviewed by telephone, we obtained 
oral informed consent before the interview.
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Ba c k g r o u n d: Despite the endocrine system activity exhibited by polychlorinated biphenyls (PCBs), 
recent studies have shown little association between PCB exposure and breast cancer mortality.
oBjectives: To further evaluate the relation between PCB exposure and breast cancer risk, we 
  studied incidence, a more sensitive end point than mortality, in an occupational cohort.
Me t h o d s : We followed 5,752 women employed for at least 1 year in one of three capacitor manu-
facturing facilities, identifying cases from questionnaires, cancer registries, and death certificates 
through 1998. We collected lifestyle and reproductive information via questionnaire from par-
ticipants or next of kin and used semiquantitative job-exposure matrices for inhalation and dermal 
exposures combined. We generated standardized incidence ratios (SIRs) and standardized rate ratios 
and used Cox proportional hazards regression models to evaluate potential confounders and effect 
modifiers.
re s u l t s: Overall, the breast cancer SIR was 0.81 (95% confidence interval, 0.72–0.92; n = 257), 
and regression modeling showed little effect of employment duration or cumulative exposure. 
However, for the 362 women of questionnaire-identified races other than white, we observed posi-
tive, statistically significant associations with employment duration and cumulative exposure; only 
smoking, birth cohort, and self- or proxy questionnaire completion had statistically significant 
explanatory power when added to models with exposure metrics.
co n c l u s i o n s: We found no overall elevation in breast cancer risk after occupational exposure to 
PCBs. However, the exposure-related risk elevations seen among nonwhite workers, although of 
limited interpretability given the small number of cases, warrant further investigation, because the 
usual reproductive risk factors accounted for little of the increased risk.
key w o r d s : breast cancer, incidence, occupational epidemiology, polychlorinated biphenyls. 
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Questionnaires. We mailed a self‑admin‑
istered questionnaire to all women or their 
next of kin for whom we could determine 
valid addresses. After two mailings and a 
reminder postcard, we telephoned nonrespon‑
dents to obtain the information. We identified 
addresses and telephone numbers using sources 
such as the Internal Revenue Service (IRS), the 
U.S. Postal Service, motor vehicle registration 
records, credit bureaus, and telephone number 
lookup services. The questionnaire collected 
information on a) incident breast and other 
cancer diagnoses and details necessary to con‑
firm diagnoses via medical records; b) relevant 
nonoccupational risk factors for breast cancer, 
such as family history and reproductive his‑
tory; and c) demographic and lifestyle infor‑
mation such as ethnicity, education, height, 
weight, and smoking history. Because we knew 
that plant 2 included a number of workers of 
Cape Verdean origin, we offered Spanish‑ and 
Portuguese‑language translations of the ques‑
tionnaire to non‑English‑speaking respondents 
upon request. Questionnaires were collected 
from 1998 through 2000. Women reporting 
breast cancer diagnoses after 1998 were not 
considered cases.
Reliable information on race was generally 
not available from plant records. For many 
deceased workers, we obtained race informa‑
tion from death certificates and other vital sta‑
tus sources. The questionnaire actively sought 
race information, asking women to select 
from the following categories: white, black, 
American Indian or Alaskan Native, Asian 
or Pacific Islander, and other. Respondents 
selecting “other” for race were prompted to 
further specify their race. The questionnaire 
asked separately whether the worker was of 
Hispanic origin.
For the present study, we used race data 
from the plants and from death certificates 
only for calculating preliminary standardized 
incidence ratios (SIRs) and standardized rate 
ratios (SRRs). In these analyses, we assumed 
workers of unknown race to be white. We lim‑
ited further analyses evaluating the effects of 
race to the subcohort with questionnaire data 
and used only the self‑ or proxy‑reported data 
to classify workers by race. This approach dif‑
fers from that used in previous studies of these 
cohorts (Prince et al. 2006a, 2006b; Ruder 
et al. 2006; Steenland et al. 2006), which used 
all data sources but prioritized questionnaire 
data. We opted to use only questionnaire‑
reported race for consistency and because of 
the potential for greater specificity.
Breast cancer ascertainment. Vital status 
follow‑up began in 1940 for the New York 
and Massachusetts facilities, and in 1957 
for the Indiana plant, which opened in that 
year. Previous mortality studies of the cohorts 
(Brown and Jones 1981; Brown 1987; Prince 
et al. 2006a, 2006b; Ruder et al. 2006) used 
Social Security Administration (SSA), state 
motor vehicle registration, and state vital sta‑
tistics offices to ascertain vital status in work‑
ers who died before 1979, and SSA, IRS, and 
National Death Index data for follow‑up after 
this date. For all time periods, we used follow‑
back services such as the U.S. Postal Service 
and credit bureaus to complete ascertainment. 
We sought death certificates from state vital 
statistics offices and had underlying cause of 
death coded by trained nosologists according 
to the International Classification of Diseases 
(ICD) revision in effect at time of death (e.g., 
World Health Organization 1977). 
For the present study, the end date for 
breast cancer incidence and mortality ascertain‑
ment was 31 December 1998. We identified 
additional breast cancer cases using question‑
naires and cancer registries. Cancer registries 
were available in all three of the states in which 
the plants were located, but for varying peri‑
ods of time (Massachusetts, 1982–1998; New 
York, 1976–1998; Indiana, 1987–1998). After 
we obtained the most current addresses, we 
evaluated the distribution by state of address 
and decided to also match our file against the 
Florida registry (covering 1981–1998) and 
the California registry (covering 1988–1998). 
Matching is done by staff at the registries, and 
data are not available to the public.
Questionnaire data were available for 
201 of the 281 identified breast cancer cases 
(72%). If the report of breast cancer by a 
woman (or her next of kin) was specifically 
contradicted by another source of information 
(e.g., the medical record), we did not include 
the report as a case (n = 10). However, we 
included breast cancer cases reported in medi‑
cal or cancer registry records (even if unre‑
ported by a woman or her next of kin) in the 
analysis (n = 82). We also included breast 
cancer cases for which we obtained no medi‑
cal record. Medical record or cancer registry 
confirmation of the diagnosis was available 
for 43% and 55% of cases, respectively.
We obtained dates of breast cancer diag‑
nosis from self‑report, proxy report, the medi‑
cal record, cancer registry record, or the death 
certificate. When diagnosis dates from mul‑
tiple sources conflicted, we used the earliest 
date considered most valid (e.g., we considered 
medical record and cancer registry dates more 
valid than self‑reported dates). For breast can‑
cer decedents with only death certificate infor‑
mation (n = 10), we used the date of death as 
the date of diagnosis unless timing of diagnosis 
was otherwise noted on the death certificate, in 
which case we adjusted the date accordingly.
Exposure estimates. Work history data 
from the three plants were collected by 
NIOSH in the mid‑1970s. The plants began 
using PCBs at different times, but the overall 
exposure period for the cohort ranged from 
1939 until 1977. We used plant‑specific 
semiquantitative JEMs to allow ranking of 
exposure intensity for all workers across all 
three plants and across time. Sources used 
to develop the JEMs included work history 
records, a small number of air samples from 
the mid‑1970s, information about historical 
process changes, job descriptions, and plant 
layouts. Separate JEMs for inhalation and der‑
mal exposures in each plant used the same scale 
for exposure scores across plants and routes of 
exposure. We used an average of inhalation 
and dermal exposure scores to create the final 
plant‑specific JEMs. These scores are unitless, 
because the dermal component could not be 
quantified; in the analysis, cumulative expo‑
sures are summed 1,000 unit‑years. The expo‑
sure assessment process has been described in 
detail (Nilsen et al. 2004a, 2004b, 2005). We 
compared serum PCB levels from a sample of 
workers at two of the three plants with cumu‑
lative exposure scores calculated via the JEMs 
for the respective plants. Cumulative expo‑
sures estimated via the JEM correlated reason‑
ably well with serum PCB levels (Steenland 
et al. 2006), with a higher correlation than 
that between duration of exposure and serum 
PCB level (Nilsen NB, Waters MA, Hein MJ, 
Ruder AM, unpublished data). Each plant had 
one department for which the exposure level 
could not be estimated but we believed to be 
low; for these departments, we used the lowest 
assigned estimate for the pertinent time period 
at that facility.
Statistical analysis. We used the NIOSH 
Personal Computer Life Table Analysis 
System (PC‑LTAS) to determine whether the 
incidence of breast cancer in the study cohort 
was higher than that expected from general 
population rates (Steenland et al. 1998). We 
constructed a referent rate file using data from 
the SEER (Surveillance, Epidemiology, and 
End Results) population for the period 1970–
1999 (Ries et al. 2002), for invasive female 
breast cancer (ICD‑9 code 174) and in situ 
breast cancer (ICD‑ 9 code 233.0). 
Analyses using SEER referent rates pro‑
duced SIRs and SRRs by categories of cumula‑
tive exposure and exposure duration, stratified 
by age (in 5‑year categories), calendar time (in 
5‑year categories), and, for some analyses, race 
(white and nonwhite). Follow‑up time began 
in 1970 when the SEER rates became avail‑
able, or 1 year after employment, whichever was 
later. Beginning follow‑up in 1970 eliminated 
24 (8.5%) of the 281 breast cancer cases and 
34.3% of the person‑time from LTAS analyses 
only. Follow‑up continued until the date of 
diagnosis, date of death, study end date (31 
December 1998), or last known date before 
loss to follow‑up, whichever was earliest. We 
also conducted lagged analyses to allow for the 
necessary latency period for solid tumors, with 
0‑, 10‑, and 15‑year lags examined. This lag dis‑
counts all exposure in the last years before the Silver et al.
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cutoff date, and sometimes results in a worker 
having no exposure or being “lagged out.” For 
exposure–response analyses, LTAS calculated a 
linear trend in a person‑year–weighted regres‑
sion of directly standardized rates, with statisti‑
cal significance of each trend determined using 
a two‑tailed Z‑test with an α of 0.05.
We conducted internal exposure–response 
analyses using Cox regression. We used the SAS 
PHREG procedure (SAS Institute Inc. 2006), 
with age as the time variable (effectively match‑
ing on age). Risk sets for each case included 
all those who started working at a younger 
age than the index case’s age at diagnosis and 
who survived without breast cancer to at least 
that age. We truncated exposure at the age of 
the index case at diagnosis. In contrast with 
the SIR/SRR analyses, we retained lagged out 
workers in the regression analyses, with a zero 
dose assigned for the lagged out period.
We limited regression analyses for the 
full cohort (5,752 workers) to exploring 
exposure metrics and birth cohort effects. 
We considered several exposure metrics: 
cumulative exposure (log‑transformed and 
untransformed), duration of exposure (log‑
transformed and untransformed), peak 
exposure, and average exposure (cumulative 
exposure divided by duration of exposure). 
We analyzed all metrics as continuous and 
categorical, with lags of 0, 10, and 15 years 
evaluated. We performed similar analyses for 
the subset of workers with some questionnaire 
data (the “questionnaire subcohort”) to see 
whether risks were similar in the two groups.
Because of the importance of certain cova‑
riates in assessing the relations between PCB 
exposure and breast cancer risk, we restricted 
further analyses to workers with complete 
questionnaire data on covariates of a priori 
interest (the “restricted subcohort”). We 
required members of the restricted subcohort 
(n = 3,141) to have data on parity, age at first 
live birth, replacement hormone use (ever 
and age at first use), whether a first‑degree 
female relative had had breast cancer, and ever 
smoked at least 100 cigarettes. We assessed 
menopausal status but did not include it as a 
restricting factor; instead, we imputed the age 
of 52 for women for whom menopausal status 
or age at menopause was missing (n = 249).
We knew from prior studies (Brown 1987; 
Brown and Jones 1981; Prince et al. 2006a, 
2006b; Ruder et al. 2006; Sinks et al. 1992) 
that the individual plants differed in exposure 
distribution, race, and percent hourly versus 
salaried, factors that could potentially affect 
breast cancer risk. Therefore, we evaluated the 
role of facility to determine whether further 
analyses should be restricted to individual 
facilities. In addition, because researchers have 
reported differences by ethnic background in 
PCB body burden in the vicinity of one of the 
plants (Choi et al. 2006), we evaluated race as a 
potential confounder warranting separate anal‑
yses. We also wanted to consider race in evalu‑
ating between facility differences, but only one 
facility (plant 2) had more than a single case 
among nonwhite workers. We also assessed the 
role of self‑ versus proxy‑reported data.
We performed covariate analyses on the 
restricted cohort, using backward elimination 
to rule out the least influential of the potential 
confounders. We also examined key interac‑
tion terms, evaluating statistical significance 
with the chi‑square likelihood ratio test.
Results
Among the full cohort of 5,752 women, the 
mean ± SD duration of employment was 7.7 ± 
4.5 years. A total of 1,413 (25%) had died by 
the study end date. We obtained completed 
questionnaires for 3,952 (69%) of the cohort, 
80% from living respondents and 20% 
from next of kin of deceased cohort mem‑
bers. The primary reason for nonresponse was 
our inability to determine a correct address 
(21%). A total of 500 former workers and 
proxy respondents (8.7%) refused to com‑
plete the questionnaire, and 112 (2%) failed 
to respond after repeated attempts.
We found 281 incident breast cancer cases 
in the full cohort. Although mortality follow‑up 
of the cohort was exhaustive, nonfatal incident 
cases occurring before initiation of the can‑
cer registries or occurring in states other than 
Massachusetts, New York, Indiana, Florida, 
and California could be ascertained only via 
questionnaire. Approximately 20% of the 
cohort did not return a questionnaire and were 
not known to be deceased at end of follow‑up; 
incident cases occurring outside the registry 
search may have been missed in this group, par‑
ticularly in the early years of follow‑up.
Of the full cohort, we identified 147 
women by plant records and death certificates 
as being of races other than white. When we 
used the questionnaire responses instead, the 
number of workers (both cases and noncases) 
identified as being of races other than white 
rose to 282. This group includes workers iden‑
tifying as members of specific races other than 
white (black, American Indian/Alaskan Native, 
Asian, or Pacific Islander), women who identi‑
fied only as “other,” and women identifying 
as multiracial. Because the number of workers 
identifying as other than white was small, we 
kept this group together for all further analyses 
and refer to it herein as “nonwhite,” although 
some women in fact selected a multiracial iden‑
tity where one of the races was white.
Of the 281 cases in the full cohort, we 
identified only eight as nonwhite from plant 
or death certificate data. However, among 
workers with complete questionnaire data on 
the covariates of a priori interest (restricted 
cohort), we identified 14 of the 145 cases as 
nonwhite. Twelve of these were from plant 
2. Of the 268 noncase workers identified as 
nonwhite on the questionnaire, 67 identi‑
fied as African American, and 201 identified 
as “other.” Most workers (n = 150) in the 
last group did not further specify their race/
ethnicity; of those who did, 90% (n = 55) 
Table 1. Characteristics of breast cancer cases and noncases.
Variable  Cases  Noncases
Entire cohort
  No. of workers  281  5,471
  Year of birth (mean ± SD)  1926 ± 11**  1930 ± 13
  Years exposed (mean ± SD)  9.3 ± 8.2**  7.7 ± 7.6
  Cumulative exposure (1,000 unit-years)
  Mean ± SD  0.67 ± 0.95  0.57 ± 0.93
  Median  0.27*  0.22
Questionnaire subcohorta
  No. of workers  201  3,751
  Year of birth (mean ± SD)  1928 ± 11**  1932 ± 12
  Self-respondent on questionnaire (%)  63.7**  82.0
  Nonwhite ethnicity (%)  7.5  9.3
  Ever-smoker (%)  51.0  52.3
  BMI at 20 years of age [kg/m2 (mean ± SD)]  20.8 ± 3.0  21.2 ± 3.2
  Age at menarche [years (mean ± SD)]  12.8 ± 1.7  12.9 ± 1.7
  Premenopausal at diagnosis (%)  15.4  NA
  Parous (%)  86.1  86.7
  No. of live births (mean ± SD)  2.5 ± 1.7  2.5 ± 1.8
  Age at first live birth [years (mean ± SD)]  23.8 ± 4.2**  23.0 ± 4.5
  Used hormone replacement therapy (%)  27.5  33.3
  Age began hormone replacement use [years (mean ± SD)]  46.5 ± 8.8  47.2 ± 9.2
  Breast cancer in first-degree female relative (%)  21.2*  13.9
  Years exposed (mean ± SD)  8.9 ± 8.2*  7.4 ± 7.4
  Cumulative exposure (1,000 unit-years)
  Mean ± SD  0.59 ± 0.84  0.52 ± 0.89
  Median  0.27  0.20
NA, not applicable.
aQuestionnaire subcohort comprises members of the full cohort for whom some questionnaire data were available. Not all 
participants (or their proxies) provided responses for each question; some variables have missing values. *p < 0.05; **p < 0.01.Occupational PCB exposure and breast cancer risk
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identified themselves solely as Cape Verdean 
or as Cape Verdean and some other ethnicity.
Table 1 provides selected demographic and 
exposure characteristics of the breast cancer 
cases and noncases in the entire cohort (n = 
5,752) and the questionnaire subcohort (n = 
3,952). In the entire cohort, on average, cases (n 
= 281) were born earlier than noncases and were 
exposed longer; these differences were highly 
statistically significant. Cases also had higher 
cumulative exposures. Breast cancer in situ was 
reported for 8 of the 281 cases (2.8%).
More data were available for the question‑
naire subcohort, including demographic and 
lifestyle characteristics. Again, cases (n = 201) 
were born significantly earlier than noncases and 
were exposed longer. Cases had higher mean 
cumulative exposure than did noncases, but 
the difference was not statistically significant. 
Cases were significantly more likely to have a 
first‑degree relative with breast cancer than were 
noncases. Average age at first live birth showed 
a slight but statistically significant difference. 
There were no statistically significant differences 
between case and noncases in the average age at 
menarche, body mass index (BMI), parity, num‑
ber of children, use of hormone replacement 
therapy, age at first use of hormone therapy, or 
in the proportion of nonwhites or ever‑smokers.
The plants differed in a number of ways. 
Most striking were the contrasts in exposure 
distributions. Mean ± SD estimated exposure 
for the workforce of plant 2 (0.80 ± 1.06, 
1,000 unit‑years) was more than twice that 
in plant 1 (0.34 ± 0.71) and was an order of 
magnitude greater than that in plant 3 (0.078 
± 0.10). The medians reflected a similar pat‑
tern (plant 2 = 0.39, plant 1 = 0.11, and plant 
3 = 0.04). Although all three facilities had 
nonwhite populations < 4% according to 
records‑based data, we classified > 15% of 
workers at plant 2 as nonwhite using ques‑
tionnaire data. The percentages of nonwhite 
workers for plants 1 and 3 increased only 
slightly when we used questionnaire data.
In the aggregate, white and nonwhite 
workers in the restricted subcohort differed on 
a number of demographic and lifestyle factors 
(Table 2). Statistically significant differences 
included higher mean and median cumula‑
tive exposures, fewer pack‑years of smoking, 
greater number of live births, and a greater 
percentage with a first‑degree female relative 
with breast cancer among nonwhite workers. 
Mean exposure durations for the two groups 
were similar. We saw more striking differ‑
ences among cases: The median exposure for 
nonwhite cases was nearly double the 75th 
percentile of exposure for white cases; in con‑
trast, for noncases, the mean was only slightly 
higher in nonwhites and the median was actu‑
ally slightly higher in whites.
SIR and SRR results reflect follow‑up 
time and cases occurring in 1970 or later, 
because of availability of SEER comparison 
data. For the full cohort, the unlagged SIR 
was 0.81 [95% confidence interval (CI), 
0.72–0.92; n = 257] and using a 10‑year lag 
was 0.81 (95% CI, 0.71–0.92; n = 251 cases).
SRRs by exposure level showed no trend 
using lagged or unlagged data. However, the 
SIRs and SRRs differed somewhat by race. 
For women identified as white by plant 
records or death certificates, the SIRs were 
0.80 (95% CI, 0.70–0.90; n = 250) and 0.80 
(95% CI, 0.70–0.90; n = 244) with 0‑ and 
10‑year lags, respectively. For women identi‑
fied as nonwhite by records (all facilities), the 
SIRs had nonsignificant elevations of 1.87 
(95% CI, 0.75–3.84; n = 7) and 1.94 (95% 
CI, 0.77–3.99; n = 7) for 0‑ and 10‑year lags 
respectively. SIRs for women with question‑
naire data were similar to those for the full 
cohort in white women (unlagged SIR = 0.84; 
95% CI, 0.72–0.97; n = 176; 10‑year lag SIR 
= 0.84; 95% CI, 0.72–0.97; n = 172) but 
showed a more modest elevation in nonwhite 
women (unlagged SIR = 1.14; 95% CI, 0.59–
1.99; n = 12; 10‑year lag SIR = 1.17; 95% 
CI, 0.06–2.03; n = 12) than that seen in the 
full cohort.
SRR results differed depending on dose 
cut points and lag (data not shown), particu‑
larly for white women, with no consistent pat‑
terns observed. In nonwhite women, trends 
were always positive and sometimes statisti‑
cally significant, depending on cut points and 
lag. However, elevations were limited to the 
highest dose categories, with deficits observed 
in some intermediate categories.
Table 3 shows results of main effects 
exposure–response analyses via Cox regression 
Table 2. Selected characteristics of restricted cohorta by race.
Variable  White (n = 2,859)  Nonwhite (n = 282)
Cases and noncases
  Year of birth (mean ± SD)  1934 ± 11.6  1933 ± 10.6
  Self-respondent on questionnaire (%)  90.0  89.0
  Ever-smoker (%)  51.8  55.0
  Pack-years (ever-smokers only) (mean ± SD)  35.2 ± 28.0  29.3 ± 24.0*
  BMI at 20 years of age [kg/m2 (mean ± SD)]  21.2 ± 3.2  21.5 ± 3.6
  Age at menarche [years (mean ± SD)]  12.9 ± 1.7  13.2 ± 1.9
  Premenopausal at diagnosis (%)  19.2  14.3
  Parous (%)  87.5  88.0
  No. of live births (mean ± SD)  2.5 ± 1.7  2.9 ± 2.1**
  Age at first live birth [years (mean ± SD)]  23.0 ± 4.4  22.5 ± 4.7
  Used hormone replacement therapy (%)  33.2  31.6
  Age began hormone replacement use [years (mean ± SD)]  47.3 ± 8.9  48.2 ± 10.4
  Breast cancer in first-degree female relative (%)  13.5  18.8*
  Years exposed (mean ± SD)  7.0 ± 7.1  6.6 ± 6.6
  Cumulative exposure (1,000 unit-years)
  Mean ± SD  0.45 ± 0.81  0.64 ± 0.88**
  Median   0.16  0.33**
Breast cancer cases only 
  No. of cases  131  14
  Cumulative exposure (1,000 unit-years)
  25th percentile  0.07  0.17
  50th percentile  0.22  1.15
  75th percentile  0.63  2.13
aRestricted cohort comprises women with questionnaire data for ever smoking, parity, age at first live birth, breast cancer 
in a first-degree female relative, hormone use, and age began hormone use. Some other variables have missing values. 
*p < 0.05; **p < 0.01.
Table 3. Main effects exposure–response results for breast cancer incidence with a 10-year lag by subco-
hort: hazard ratio (95% CI).
    Questionnaire  Restricted
  Full cohort  subcohorta  subcohortb
 ( n = 5,752,  (n = 3,952,  (n = 3,141,
Variable  cases = 281)  cases = 201)  cases = 145)
Model 1
Cumulative exposure (per 1,000 unit-years)  1.01 (0.96–1.05)  1.00 (0.94–1.06)  1.04 (0.97–1.11)
  Born < 1920 (reference group)  1.00  1.00  1.00
  Born 1920–1934  1.63 (1.19–2.23)  1.71 (1.14–2.57)  1.64 (0.96–2.83)
  Born ≥ 1935  2.47 (1.65–3.70)  2.86 (1.74–4.71)  3.40 (1.79–6.46)
Model 2
Years exposed  1.01 (0.99–1.03)  1.01 (0.99–1.03)  1.02 (1.00–1.05)
  Born < 1920 (reference group)  1.00  1.00  1.00
  Born 1920–1934  1.62 (1.18–2.22)  1.72 (1.14–2.58)  1.66 (0.96–2.86)
  Born ≥ 1935  2.50 (1.67–3.75)  2.93 (1.78–4.84)  3.52 (1.85–6.72)
aQuestionnaire subcohort comprises members of the full cohort for whom some questionnaire data were available. 
bRestricted cohort comprises women with questionnaire data for ever smoking, parity, age at first live birth, breast cancer 
in first-degree female relative, hormone use, and age began hormone use.Silver et al.
280  v o l u m e  117 | n u m b e r 2 | February 2009  •  Environmental Health Perspectives
using the full, questionnaire, and restricted 
cohorts. To account for secular trends in 
breast cancer incidence, all models included 
variables for birth cohort (before 1920 as a 
referent, 1920–1934, and ≥ 1935). Although 
the exposure metrics were right skewed, the 
untransformed metrics fit the data best. For 
the full cohort, neither of the exposure metrics 
achieved statistical significance. Cumulative 
exposure was not associated with elevations 
in breast cancer incidence for the full cohort, 
the questionnaire subcohort, or the restricted 
subcohort; exposure duration showed a statis‑
tically significant association with risk only in 
the restricted cohort. Results for external and 
internal analyses did not differ greatly with 
the inclusion or exclusion of in situ cases.
Because the SRR results suggested a differ‑
ence in risk by race, we evaluated the effects of 
race in the regression analyses and then con‑
ducted further evaluations of potential con‑
founders and effect modifiers in the restricted 
cohort separately for nonwhite and white 
women. Table 4 provides the results of these 
analyses. Although the unlagged model fit best 
for most exposure metrics (cumulative, dura‑
tion) in white women, a 10‑year lag fit better 
in nonwhite women. We had doubts about 
the biologic plausibility of a zero lag and chose 
the 10‑year lag for further modeling.
Among white women, cumulative expo‑
sure and duration of exposure had little 
effect on breast cancer risk. Birth cohort was 
significant, with an increased risk for the 
group born during the period 1920–1934 
and a larger increase compared with base‑
line for those born after 1934. Beyond birth 
cohort, the covariates retained in the model 
were parity, family history of breast cancer, 
and self‑ versus proxy questionnaire comple‑
tion. Plant did not strongly affect the rela‑
tion between the exposure metrics and breast 
cancer risk, and we eliminated this variable 
from the model. Use of hormone replacement 
therapy, although technically a confounder, 
had a lesser effect on risk, and we also elimi‑
nated this variable from the final model in the 
interest of parsimony. Menopausal status was 
not a confounder in this group.
In contrast, among nonwhite women, the 
effects of increasing exposure were positive 
and statistically significant. Both cumulative 
exposure (continuous) and duration of expo‑
sure were highly associated with breast cancer 
risk. Categorical exposure was associated with 
elevated risk at the two highest levels, but not 
in the intermediate category. The variables 
usually considered breast cancer risk fac‑
tors (family history, parity, use of hormone 
replacement therapy, menopausal status) 
had little effect on risk in this group (data 
not shown). The most important covariates 
for this cohort were ever‑smoking, source of 
questionnaire data, and birth cohort (limited 
to those women born after 1934). In uni‑
variate analyses, nonwhite cases smoked more 
than noncases (46 vs. 29 pack‑years), in part 
because they smoked for more years (42.6 
vs. 32.9). We did not observe these patterns 
among white workers. To assess whether 
smoking might be a proxy for alcohol use, 
we examined models with smoking but not 
alcohol, with alcohol but not smoking, and 
with both alcohol and smoking and found 
that only smoking had significant explana‑
tory value.
To further explore the effects of smoking 
in nonwhite workers, we considered current 
smoking status (at time of death for deceased 
workers or time of questionnaire completion 
for living workers) and pack‑years. Adding 
pack‑years or current smoking status to a 
model that included ever smoking had little 
effect. The interaction between current smok‑
ing status and cumulative exposure nearly 
attained statistical significance (p = 0.06).
Because the mean and median PCB expo‑
sure estimates were significantly higher among 
nonwhite workers, we considered the possibil‑
ity that the greater risk observed in nonwhite 
women was attributable to a high‑exposure 
effect. We reevaluated the exposure risk in 
white women using the same cut points 
employed for nonwhite women and found 
the same lack of trend we observed with the 
original quartile‑based cut points. The lack 
of exposure–response in white women does 
not appear to be related to the lower exposure 
levels in this group.
Discussion
In this study of breast cancer incidence among 
female workers employed in capacitor pro‑
duction facilities, differences in risk by race, 
although subject to a number of caveats, were 
evident. In white women, the SIR was below 
expectation, and in the modeling analyses, the 
very small positive exposure response observed 
was largely explained by the well‑known risk 
factors parity, age at first live birth, and family 
history of breast cancer. Differences between 
the SIR and exposure–response results likely 
resulted from differences in covariate control, 
in addition to differences between the subco‑
horts used in the SIR and regression analyses; 
despite these differences, we observed no sta‑
tistically significant elevation of risk in any 
subcohort of white women. These results sug‑
gest that among white women, if there is a 
relation of PCB exposure with breast cancer 
risk, it is likely quite modest, even at the rela‑
tively high levels characteristic of occupation‑
ally exposed populations.
In contrast, among nonwhite women, 
whereas the SIR was close to expectation, 
the strong, positive exposure response seen in 
regression analyses was only modestly attenu‑
ated by smoking, birth cohort, and source of 
questionnaire data (self or proxy), the only 
covariates with significant explanatory power. 
Table 4. Full models for breast cancer incidence with a 10-year lag, restricted subcohorta by race.
Variable  Hazard ratio (95% CI)
White women (131 cases)
Model 1: Continuous cumulative exposure (per 1,000 unit-years)  1.00 (1.00–1.00)
  Born < 1920 (reference group)  1.00 
  Born 1920–1934  3.07 (1.63–5.78)
  Born ≥ 1935  7.81 (3.65–16.7)
  Self-respondent  0.31 (0.19–0.50)
  Parous  0.30 (0.10–0.84)
  Age at first live birth  1.07 (1.03–1.11)
  Positive family history  1.60 (1.05–2.44)
Model 2: Years exposedb  1.02 (0.99–1.05)
Model 3: Categorical cumulative exposure (per 1,000 unit-years)b 
  0 to < 0.16 (n = 32)  1.00
  0.16 to < 0.46 (n = 33)  1.36 (0.83–2.23)
  0.46 to < 1.6 (n = 34)  1.15 (0.70–1.89)
  ≥ 1.6 (n = 32)  1.27 (0.75–2.17)
Nonwhite women (14 cases)
Model 4: Continuous cumulative exposure (per 1,000 unit-years)  1.33 (1.14–1.56)
  Born < 1920 (reference group)  1.00
  Born 1920–1934  0.94 (0.22–4.07)
  Born ≥ 1935  3.75 (0.51–27.8)
  Self-respondent  0.07 (0.02–0.26)
  Ever-smoker  3.84 (1.01–14.6)
Model 5: Years exposedc  1.13 (1.03–1.23)
Model 6: Categorical cumulative exposure (per 1,000 unit-years)c 
  < 0.47 (n = 4)  1.00
  0.47 to < 3.9 (n = 3)  0.60 (0.12–3.01)
  3.9 to < 5.8 (n = 4)  7.65 (1.11–52.8)
  ≥ 5.8 (n = 3)  22.3 (2.38–209)
aRestricted cohort comprises women with questionnaire data for ever smoking, parity, age at first live birth, breast cancer 
in first-degree female relative, hormone use, and age began hormone use. bModels control for birth cohort (1920–1934, 
≥ 1935, vs. < 1920); self-respondent, parity, age at first live birth, and positive family history). cModels control for birth 
cohort (1920–1934, ≥ 1935, vs. <1920); self-respondent and ever-smoker).Occupational PCB exposure and breast cancer risk
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Race was not a variable of strong a priori 
interest, and these findings may be the result 
of chance or uncontrolled confounding. The 
small number of nonwhite cases further limits 
interpretation of the findings in this group.
In both white and nonwhite women, risk 
of breast cancer after PCB exposure was lower 
for women born before 1920 than for those 
born after 1934. The pattern of increasing 
breast cancer incidence risk for later birth 
cohorts is generally consistent with results 
reported from the SEER registry (Holford 
et al. 2006) and the Connecticut Cancer 
Registry (Holford et al. 1991).
The study has several potential limitations. 
Response bias is a possibility when question‑
naires are used. If nonrespondents had lower 
breast cancer rates than respondents, an artifi‑
cial excess of breast cancer would be observed in 
the exposed population versus the nonexposed 
referent population. To minimize the likeli‑
hood of such bias, the study materials referred 
not to breast cancer but to “health effects.”
Of greater concern is that ascertainment 
of incident breast cancer cases was likely 
better for the later years of the study, when 
cancer registry data were available to supple‑
ment death records and questionnaire data. 
Although we identified only 10 breast can‑
cer deaths using death certificates alone, it is 
likely that nonfatal incident cases were missed 
in the early years. This would lead to underes‑
timates of the SIR and could affect exposure–
response analyses, because early exposures 
were substantially higher than those in later 
years. In addition, this could affect observed 
secular trends. On the other hand, we could 
not verify some of the cases identified via 
questionnaire either by medical records or by 
a cancer registry, so we cannot rule out lim‑
ited overascertainment.
Completion of questionnaires by proxy 
respondents likely introduced misclassifica‑
tion on some covariates. Proxy respondents 
often left blanks in response to some ques‑
tions, so the restricted cohort underrepresents 
deceased workers. In addition, proxy respon‑
dents may also have been less accurate in 
responses to questions they did answer. When 
we performed a sensitivity analysis evaluating 
proxy and self‑respondents in the restricted 
cohort separately, we found that results for 
each group were quite similar to those for all 
respondents combined, although risk estimates 
were slightly higher among self‑respondents.
Errors in reporting of smoking are 
potentially problematic, given the results in 
nonwhite women. Studies have shown that 
smoking status is reported more accurately by 
proxies than was number of cigarettes smoked 
(Lerchen and Samet 1986; Steenland and 
Schnorr 1988). We used ever/never in the 
final model to minimize reporting bias and 
to avoid further restricting the cohort. The 
positive exposure response persisted whether 
we included or excluded smoking covariates.
Misclassification of PCB exposure is 
another potential limitation. We assessed 
exposure levels by job title, department, and 
work process, with limited air sampling data 
available from the 1970s only. The combina‑
tion of dermal and inhalation exposures into 
a single semiquantitative estimate does not 
account for differences in doses by route of 
exposure. In addition, the use of total PCBs 
as the exposure metric may obscure the effects 
of individual congeners or subgroups.
Race, although an important predictor 
for breast cancer risk after PCB exposure in 
this study, is not well defined for this cohort. 
In addition to general concerns about using 
race in place of more specific information 
about genetics to explain disease risk (Harty 
et al. 2006; Kolonel et al. 2004), this study is 
hampered by marked discrepancies between 
race identified from records‑based sources 
and race identified via questionnaire. In addi‑
tion, whereas most nonwhite workers who 
more fully specified their race via question‑
naire identified as either African American 
or Cape Verdean, more than half of the non‑
white workers self‑identified as “other” and 
failed to further define their race. The poten‑
tial for marked heterogeneity among those 
identifying as “other,” as well as the small 
number of nonwhite cases, cautions against 
overinterpretation.
Further specification of ethnic origins of 
all members of the cohort would be of interest 
because other studies raise the possibility that 
differences in nonoccupational exposure levels 
and/or genetic susceptibility could contribute 
to observed differences in risk by race. A study 
of women residing near a PCB‑contaminated 
harbor in New Bedford, Massachusetts, close 
to where plant 2 is located, found higher PCB 
levels in infants of women from Portugal, the 
Azores, and Cape Verde compared with those 
born in the United States, Canada, or other 
countries (Choi et al. 2006). The authors con‑
sidered the contributions of diet (i.e., fish con‑
sumption) but not occupational exposures. 
In addition, studies have found race‑related 
differences in genetic polymorphisms that may 
affect PCB metabolism (Li et al. 2005), and 
slight elevations in breast cancer risk after PCB 
exposure in postmenopausal African‑American 
women with CYP1A1 M3 genotypes who 
smoked > 20 years (Li et al. 2004), suggesting 
the possibility of complex interactions between 
genes, lifestyle factors, and PCB‑related breast 
cancer risk in a population subset.
Smoking is not generally considered a risk 
factor for breast cancer. The smoking results 
in the present study may represent a chance 
finding, or smoking may be a proxy for some 
other risk factor (although we ruled out alco‑
hol, one obvious possibility) or a vehicle 
for greater but unmeasured PCB exposure 
through hand‑to‑mouth ingestion.
The lack of any significant overall increase 
in risk of breast cancer after PCB exposure 
in this occupational cohort is reassuring and 
consistent with the results of previous stud‑
ies of the contributing cohorts (Prince et al. 
2006a, 2006b; Ruder et al. 2006). Chance 
and residual confounding cannot be ruled 
out as explanations for the positive relation 
between PCB exposure and breast cancer risk 
among nonwhite women; however, this find‑
ing, which was not attenuated by reproductive 
factors, warrants further exploration.
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